Conservative Group Pushes for FDA Approval of Drug to Treat Coronavirus
March 26 2020 - 10:00AM
Dow Jones News
By Julie Bykowicz
The conservative pro-business group Job Creators Network is
asking U.S. doctors to advocate for federal approval of the
anti-malaria drug hydroxychloroquine as a treatment for the new
coronavirus.
In text messages and targeted Facebook ads that began this week,
the group steers recipients to a petition to President Trump that
asks him to "immediately cut through this red tape" to get more
hydroxychloroquine into the marketplace, noting the drug is in
short supply. There is no strong evidence that the drug has
anti-coronavirus effects, though the U.S. is now testing that
theory.
Home Depot co-founder and longtime Republican donor Bernard
Marcus formed the Job Creators Network about a decade ago. Mr.
Marcus was a donor to Mr. Trump's 2016 campaign and said he will
support his re-election bid. Job Creators Network bills itself as
an advocate for small business interests in Washington and in 2018
spent more than $5 million on a bus tour promoting the tax cuts
that Mr. Trump had signed into law, according to its tax
documents.
Job Creators Network declined to identify who is funding the
petition drive, which the group says is costing just over $10,000.
The nonprofit foundation arm of the group is named on the ads. Past
funding for the network has come from hedge fund founder Robert
Mercer's family foundation, according to tax documents, and its
board includes executives of large companies.
The business group's goal is murky: It is asking Mr. Trump to do
something he already wants to do -- obtain Food and Drug
Administration approval to treat the coronavirus with
hydroxychloroquine. Even without that green light, doctors already
are able to prescribe it.
Drug makers Novartis, Mylan and Amneal have pledged in recent
days to produce more hydroxychloroquine, noting its potential use
in the fight against the global pandemic.
The Job Creators Network began its petition drive after hearing
about hydroxychloroquine from doctors it has worked with since last
fall on an unrelated push for a free-market health care system,
said Elaine Parker, a spokeswoman for the network.
"We're not advocating that people should take the drug," Ms.
Parker said. "We're advocating that doctors should have the
opportunity to prescribe it if they want to do so. The problem is
no one can find it. It's a supply-side issue."
She said the group hopes Mr. Trump can "ungum the bureaucracy"
and get more hydroxychloroquine to market. She said she expects to
get the petition to the White House by the end of this week and
said about 700 physicians have signed it so far.
Mr. Trump first mentioned hydroxychloroquine and other potential
coronavirus treatments at a press conference March 19, and he
asserted that the FDA had already approved it for that use. FDA
Commissioner Stephen Hahn immediately said that wasn't accurate,
and that the drug would be available "in the setting of a clinical
trial."
There has been little research on the efficacy of
hydroxychloroquine in treating coronavirus; testing has only been
conducted on a small number of patients. In addition to malaria,
the drug is also used to treat rheumatoid arthritis and lupus. New
York Gov. Andrew Cuomo said a study of hydroxychloroquine and
coronavirus was scheduled to start earlier this week.
The Job Creators Network petition says that in addition to a
national shortage of hydroxychloroquine, "there is growing pressure
to prevent physicians from treating the coronavirus with
hydroxychloroquine as it is 'off label.'"
Advocacy groups for lupus and arthritis patients said some
people who need hydroxychloroquine for approved treatments have
already begun having trouble getting the drug.
"We can't forget about the people who need the drug right now,"
said Mike Donnelly, a spokesman for Lupus Foundation of
America.
Lupus Foundation of America, American College of Rheumatology,
American Academy of Dermatology, and the Arthritis Foundation sent
a letter Monday to the White House Coronavirus Task Force
expressing concern that the interest in using the drug for the new
coronavirus has "exacerbated their already limited availability for
patients who rely on them to meet their medical needs."
Ms. Parker said doctors have seen hydroxychloroquine work for
coronavirus patients, too. Some doctors who have appeared on Fox
News programs favored by the president have also promoted it.
The Job Creators Network petition cites Physicians for Reform as
a partner. The nonprofit group has seen almost no funding in recent
years, its tax forms show. The group's president, Dr. C.L. Gray, a
North Carolina physician, said in a statement provided by the Job
Creators Network that hydroxychloroquine "may be one of the best
treatments available (as of today)" and yet "it remains essentially
unavailable in communities such as my own."
Dr. Gray said the petition "will draw attention to this
problem."
Several doctors have flagged the text messages on social media,
expressing skepticism about the push. "The stupid is coming in by
texts now," one Twitter user whose bio says he is a cardiologist
wrote.
A screen shot he and other doctors shared on Twitter reads,
"Tell Trump to CUT RED TAPE & make hydroxychloroquine available
to you and your patients" and links to the petition to the
president.
A small batch of Facebook ads linking to the same petition began
circulating on Tuesday, the social media site's advertising
database shows. "Doctors who think hydroxychloroquine needs to be
approved to fight coronavirus need to make their voice heard NOW.
Please sign our petition which will go directly to President
Trump," the ads say.
Write to Julie Bykowicz at julie.bykowicz@wsj.com
(END) Dow Jones Newswires
March 26, 2020 09:45 ET (13:45 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Meta Platforms (NASDAQ:META)
Historical Stock Chart
From Apr 2024 to May 2024
Meta Platforms (NASDAQ:META)
Historical Stock Chart
From May 2023 to May 2024